SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4476ISIS giving a nice lil return for the patient off the 11 lows now nearing 13 thSusan Saline-5/15/2008
4475cc transcript seekingalpha.combob zagorin-5/12/2008
4474Isis Reports Financial Results and Highlights for First Quarter of 2008 Monday Mbob zagorin-5/12/2008
4473Future of lucrative cholesterol drugs murky Sun May 4, 2008 10:07am EDT By Billbob zagorin-5/4/2008
4472little more color on FDA in the mrk story.. Cholesterol-drug rejection rips newbob zagorin-4/30/2008
4471ISIS way oversold started position here 11.88 will stop out at 11.00 if it conSusan Saline-4/30/2008
4470FDA rejections suggest higher bar for cholesterol drugs Tuesday April 29, 2:56 pbob zagorin-4/29/2008
4469motley fool.. FDA Moves Isis' Finish Line By Brian Orelli April 28, 2008 Ibob zagorin-4/29/2008
4468Hi Steve, Wanted to kind of clarify a few points and perhaps stimulate some disDr. Voodoo-4/28/2008
4467Isis and Genzyme Must Prove Benefits of Cholesterol Drug By PETER LOFTUS (WSJ) Abob zagorin-4/28/2008
4466WACHOVIA SUMMARY- SELL-OFF OVERDONE/2011 VALUATION DOWN ON FDA CHANGES ISIS: Mipbob zagorin-4/28/2008
4465If you fear that "the outcomes trials are high risk," you should weighArt Bechhoefer-4/27/2008
4464If ISIS wanted to test Mipomersen for, as you put it, "reduction in cardiacArt Bechhoefer-4/27/2008
4463Your fear of mandated free drugs runs counter to the policies and plans of all pArt Bechhoefer-4/27/2008
4462From article Dr Voodoo posted; <i>They said user fees compromise safety aSteve Lokness-4/27/2008
4461Perhaps I'm being naive, but I don't think the renegotiation is so likeltuck-4/27/2008
4460that is exactly why ISIS needs to run an outcome trial and <b>demonstrate Casaubon-4/27/2008
4459washingtonpost.com I outlined my concerns to Causubon. You're thougts are Dr. Voodoo-4/26/2008
4458The "clinical benefit" was reduction of arterial plaques. That's nDr. Voodoo-4/26/2008
4457FWIW, I have been long Isis for... um... longer than SI has been in existence. Dr. Voodoo-4/26/2008
4456I'm not certain what you said, so I'll reiterate my position. The outcoCasaubon-4/26/2008
4455Yes but if and only if the "outcome" is lowering bad cholesterol, raisDr. Voodoo-4/26/2008
4454I don't see it that way, in this instance. Vytorin met the surrogate markerCasaubon-4/26/2008
4453<i>The FDA wants perfectly safe drugs</i> Or, isn't there anothArt Bechhoefer-4/26/2008
4452Words well spoken Dr. Voodoo. FDA - Big UGH! LJM-4/26/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News